United States Kinase Inhibitors Market Report 2017

Publisher Name :
Date: 04-Dec-2017
No. of pages: 104
Inquire Before Buying

In this report, the United States Kinase Inhibitors market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Kinase Inhibitors in these regions, from 2012 to 2022 (forecast).

United States Kinase Inhibitors market competition by top manufacturers/players, with Kinase Inhibitors sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- Boehringer Ingelheim

- Cytrx Corporation

- Eton Bioscience Inc.

- Glaxosmithkline

- Bristol-Myers Squibb

- Osi Pharmaceuticals Llc

- Pfizer

- Eisai Inc.

- Merck Serono Sa

- Novartis International Ag

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Tyrosin Kinase Inhibitors (TKI)

- Receptor Tyrosine Kinase Inhibitors

- Non-Receptor Tyrosine Kinase Inhibitors

- Mulikinase Inhibitors

- Threonine Kinase Inhibitors

- mTOR Kinase Inhibitors

- RHO Kinase Inhibitors

- Cyclin Dependant Kinase Inhibitors

- Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Pharmaceutical

- Health Care Products

- Scientific Research

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Kinase Inhibitors Market Report 2017

Table of Contents
United States Kinase Inhibitors Market Report 2017
1 Kinase Inhibitors Overview
1.1 Product Overview and Scope of Kinase Inhibitors
1.2 Classification of Kinase Inhibitors by Product Category
1.2.1 United States Kinase Inhibitors Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Kinase Inhibitors Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Tyrosin Kinase Inhibitors (TKI)
1.2.4 Receptor Tyrosine Kinase Inhibitors
1.2.5 Non-Receptor Tyrosine Kinase Inhibitors
1.2.6 Mulikinase Inhibitors
1.2.7 Threonine Kinase Inhibitors
1.2.8 mTOR Kinase Inhibitors
1.2.9 RHO Kinase Inhibitors
1.2.10 Cyclin Dependant Kinase Inhibitors
1.2.11 Others
1.3 United States Kinase Inhibitors Market by Application/End Users
1.3.1 United States Kinase Inhibitors Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Pharmaceutical
1.3.3 Health Care Products
1.3.4 Scientific Research
1.4 United States Kinase Inhibitors Market by Region
1.4.1 United States Kinase Inhibitors Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Kinase Inhibitors Status and Prospect (2012-2022)
1.4.3 Southwest Kinase Inhibitors Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Kinase Inhibitors Status and Prospect (2012-2022)
1.4.5 New England Kinase Inhibitors Status and Prospect (2012-2022)
1.4.6 The South Kinase Inhibitors Status and Prospect (2012-2022)
1.4.7 The Midwest Kinase Inhibitors Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Kinase Inhibitors (2012-2022)
1.5.1 United States Kinase Inhibitors Sales and Growth Rate (2012-2022)
1.5.2 United States Kinase Inhibitors Revenue and Growth Rate (2012-2022)
2 United States Kinase Inhibitors Market Competition by Players/Suppliers
2.1 United States Kinase Inhibitors Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Kinase Inhibitors Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Kinase Inhibitors Average Price by Players/Suppliers (2012-2017)
2.4 United States Kinase Inhibitors Market Competitive Situation and Trends
2.4.1 United States Kinase Inhibitors Market Concentration Rate
2.4.2 United States Kinase Inhibitors Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Kinase Inhibitors Manufacturing Base Distribution, Sales Area, Product Type
3 United States Kinase Inhibitors Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Kinase Inhibitors Sales and Market Share by Region (2012-2017)
3.2 United States Kinase Inhibitors Revenue and Market Share by Region (2012-2017)
3.3 United States Kinase Inhibitors Price by Region (2012-2017)
4 United States Kinase Inhibitors Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Kinase Inhibitors Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Kinase Inhibitors Revenue and Market Share by Type (2012-2017)
4.3 United States Kinase Inhibitors Price by Type (2012-2017)
4.4 United States Kinase Inhibitors Sales Growth Rate by Type (2012-2017)
5 United States Kinase Inhibitors Sales (Volume) by Application (2012-2017)
5.1 United States Kinase Inhibitors Sales and Market Share by Application (2012-2017)
5.2 United States Kinase Inhibitors Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Kinase Inhibitors Players/Suppliers Profiles and Sales Data
6.1 Boehringer Ingelheim
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Kinase Inhibitors Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Boehringer Ingelheim Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Cytrx Corporation
6.2.2 Kinase Inhibitors Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Cytrx Corporation Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Eton Bioscience Inc.
6.3.2 Kinase Inhibitors Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Eton Bioscience Inc. Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Glaxosmithkline
6.4.2 Kinase Inhibitors Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Glaxosmithkline Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Bristol-Myers Squibb
6.5.2 Kinase Inhibitors Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Bristol-Myers Squibb Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Osi Pharmaceuticals Llc
6.6.2 Kinase Inhibitors Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Osi Pharmaceuticals Llc Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Pfizer
6.7.2 Kinase Inhibitors Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Pfizer Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Eisai Inc.
6.8.2 Kinase Inhibitors Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Eisai Inc. Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Merck Serono Sa
6.9.2 Kinase Inhibitors Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Merck Serono Sa Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Novartis International Ag
6.10.2 Kinase Inhibitors Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Novartis International Ag Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
7 Kinase Inhibitors Manufacturing Cost Analysis
7.1 Kinase Inhibitors Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Kinase Inhibitors
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Kinase Inhibitors Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Kinase Inhibitors Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Kinase Inhibitors Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Kinase Inhibitors Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Kinase Inhibitors Sales Volume Forecast by Type (2017-2022)
11.3 United States Kinase Inhibitors Sales Volume Forecast by Application (2017-2022)
11.4 United States Kinase Inhibitors Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Kinase Inhibitors
Figure United States Kinase Inhibitors Market Size (K MT) by Type (2012-2022)
Figure United States Kinase Inhibitors Sales Volume Market Share by Type (Product Category) in 2016
Figure Tyrosin Kinase Inhibitors (TKI) Product Picture
Figure Receptor Tyrosine Kinase Inhibitors Product Picture
Figure Non-Receptor Tyrosine Kinase Inhibitors Product Picture
Figure Mulikinase Inhibitors Product Picture
Figure Threonine Kinase Inhibitors Product Picture
Figure mTOR Kinase Inhibitors Product Picture
Figure RHO Kinase Inhibitors Product Picture
Figure Cyclin Dependant Kinase Inhibitors Product Picture
Figure Others Product Picture
Figure United States Kinase Inhibitors Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Kinase Inhibitors by Application in 2016
Figure Pharmaceutical Examples
Table Key Downstream Customer in Pharmaceutical
Figure Health Care Products Examples
Table Key Downstream Customer in Health Care Products
Figure Scientific Research Examples
Table Key Downstream Customer in Scientific Research
Figure United States Kinase Inhibitors Market Size (Million USD) by Region (2012-2022)
Figure The West Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Kinase Inhibitors Sales (K MT) and Growth Rate (2012-2022)
Figure United States Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Kinase Inhibitors Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Kinase Inhibitors Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Kinase Inhibitors Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Kinase Inhibitors Sales Share by Players/Suppliers
Figure 2017 United States Kinase Inhibitors Sales Share by Players/Suppliers
Figure United States Kinase Inhibitors Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Kinase Inhibitors Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Kinase Inhibitors Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Kinase Inhibitors Revenue Share by Players/Suppliers
Figure 2017 United States Kinase Inhibitors Revenue Share by Players/Suppliers
Table United States Market Kinase Inhibitors Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Kinase Inhibitors Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Kinase Inhibitors Market Share of Top 3 Players/Suppliers
Figure United States Kinase Inhibitors Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Kinase Inhibitors Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Kinase Inhibitors Product Category
Table United States Kinase Inhibitors Sales (K MT) by Region (2012-2017)
Table United States Kinase Inhibitors Sales Share by Region (2012-2017)
Figure United States Kinase Inhibitors Sales Share by Region (2012-2017)
Figure United States Kinase Inhibitors Sales Market Share by Region in 2016
Table United States Kinase Inhibitors Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Kinase Inhibitors Revenue Share by Region (2012-2017)
Figure United States Kinase Inhibitors Revenue Market Share by Region (2012-2017)
Figure United States Kinase Inhibitors Revenue Market Share by Region in 2016
Table United States Kinase Inhibitors Price (USD/MT) by Region (2012-2017)
Table United States Kinase Inhibitors Sales (K MT) by Type (2012-2017)
Table United States Kinase Inhibitors Sales Share by Type (2012-2017)
Figure United States Kinase Inhibitors Sales Share by Type (2012-2017)
Figure United States Kinase Inhibitors Sales Market Share by Type in 2016
Table United States Kinase Inhibitors Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Kinase Inhibitors Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Kinase Inhibitors by Type (2012-2017)
Figure Revenue Market Share of Kinase Inhibitors by Type in 2016
Table United States Kinase Inhibitors Price (USD/MT) by Types (2012-2017)
Figure United States Kinase Inhibitors Sales Growth Rate by Type (2012-2017)
Table United States Kinase Inhibitors Sales (K MT) by Application (2012-2017)
Table United States Kinase Inhibitors Sales Market Share by Application (2012-2017)
Figure United States Kinase Inhibitors Sales Market Share by Application (2012-2017)
Figure United States Kinase Inhibitors Sales Market Share by Application in 2016
Table United States Kinase Inhibitors Sales Growth Rate by Application (2012-2017)
Figure United States Kinase Inhibitors Sales Growth Rate by Application (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Cytrx Corporation Basic Information List
Table Cytrx Corporation Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Cytrx Corporation Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Cytrx Corporation Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Cytrx Corporation Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Eton Bioscience Inc. Basic Information List
Table Eton Bioscience Inc. Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eton Bioscience Inc. Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Eton Bioscience Inc. Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Eton Bioscience Inc. Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Glaxosmithkline Basic Information List
Table Glaxosmithkline Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Glaxosmithkline Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Glaxosmithkline Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Glaxosmithkline Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Osi Pharmaceuticals Llc Basic Information List
Table Osi Pharmaceuticals Llc Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Osi Pharmaceuticals Llc Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Osi Pharmaceuticals Llc Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Osi Pharmaceuticals Llc Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Pfizer Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Pfizer Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Eisai Inc. Basic Information List
Table Eisai Inc. Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eisai Inc. Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Eisai Inc. Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Eisai Inc. Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Merck Serono Sa Basic Information List
Table Merck Serono Sa Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck Serono Sa Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Merck Serono Sa Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Merck Serono Sa Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Novartis International Ag Basic Information List
Table Novartis International Ag Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis International Ag Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Novartis International Ag Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Novartis International Ag Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Kinase Inhibitors
Figure Manufacturing Process Analysis of Kinase Inhibitors
Figure Kinase Inhibitors Industrial Chain Analysis
Table Raw Materials Sources of Kinase Inhibitors Major Players/Suppliers in 2016
Table Major Buyers of Kinase Inhibitors
Table Distributors/Traders List
Figure United States Kinase Inhibitors Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Kinase Inhibitors Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Kinase Inhibitors Price (USD/MT) Trend Forecast (2017-2022)
Table United States Kinase Inhibitors Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Kinase Inhibitors Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Kinase Inhibitors Sales Volume (K MT) Forecast by Type in 2022
Table United States Kinase Inhibitors Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Kinase Inhibitors Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Kinase Inhibitors Sales Volume (K MT) Forecast by Application in 2022
Table United States Kinase Inhibitors Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Kinase Inhibitors Sales Volume Share Forecast by Region (2017-2022)
Figure United States Kinase Inhibitors Sales Volume Share Forecast by Region (2017-2022)
Figure United States Kinase Inhibitors Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Reverse Transcriptase Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Jul-2018        Price: US 3480 Onwards        Pages: 135
    Normally, DNA is transcribed, or copied, to RNA and then translated to protein. Reverse transcriptase copies RNA back to DNA. Think of it as a car moving down a one-way street. Normally traffic only moves in one direction. But then, someone from out of town is driving the opposite way! Reverse transcriptase drives the opposite way in molecular processes in cells, converting RNA back to DNA. Although it is very different from the normal process, reverse transcriptase is an important ......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Reverse Transcriptase Market 2018, Forecast to 2023
    Published: 20-Jul-2018        Price: US 4880 Onwards        Pages: 129
    Normally, DNA is transcribed, or copied, to RNA and then translated to protein. Reverse transcriptase copies RNA back to DNA. Think of it as a car moving down a one-way street. Normally traffic only moves in one direction. But then, someone from out of town is driving the opposite way! Reverse transcriptase drives the opposite way in molecular processes in cells, converting RNA back to DNA. Although it is very different from the normal process, reverse transcriptase is an important ......
  • Global Cellulase (CAS 9012-54-8) Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Jul-2018        Price: US 3480 Onwards        Pages: 137
    Cellulose is a linear polysaccharide of glucose residues connected by ß-1,4 linkages. Like chitin it is not cross-linked. Native crystalline cellulose is insoluble and occurs as fibers of densely packed, hydrogen bonded, anhydroglucose chains of 15 to 10,000 glucose units. Its density and complexity make it very resistant to hydrolysis without preliminary chemical or mechanical degradation or swelling. In nature cellulose is usually associated with other polysaccharides such as xylan or lignin. ......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Cellulase (CAS 9012-54-8) Market 2018, Forecast to 2023
    Published: 20-Jul-2018        Price: US 4880 Onwards        Pages: 128
    Cellulose is a linear polysaccharide of glucose residues connected by ß-1,4 linkages. Like chitin it is not cross-linked. Native crystalline cellulose is insoluble and occurs as fibers of densely packed, hydrogen bonded, anhydroglucose chains of 15 to 10,000 glucose units. Its density and complexity make it very resistant to hydrolysis without preliminary chemical or mechanical degradation or swelling. In nature cellulose is usually associated with other polysaccharides such as xylan or lignin. ......
  • Global Alcohol Dehydrogenase Market Professional Survey Report 2018
    Published: 19-Jul-2018        Price: US 3500 Onwards        Pages: 105
    This report studies the global Alcohol Dehydrogenase market status and forecast, categorizes the global Alcohol Dehydrogenase market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). Alcohol dehydrogenase (ADH), part of the oxidoreductase family, catalyzes the oxidation of alcohols, us......
  • Global and United States Specialty Enzymes Market Research by Company, Type & Application 2013-2025
    Published: 14-Jul-2018        Price: US 2000 Onwards        Pages: 115
    Summary Market Segment as follows: By Type - Protease - Carbohydrases - Polymerases and Nucleases - Lipase - Others By Application - Research & Biotechnology - Diagnostics - Other specialty By Company - Novozymes A/S - Amano Enzymes Inc. - Codexis Inc. - Advanced Enzymes Technologies Ltd. - Affymetrix Inc. - BBI Solutions - Roche CustomBiotech - Biocatalysts......
  • Global Phytases Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 13-Jul-2018        Price: US 3480 Onwards        Pages: 131
    This report studies the Phytases market, A phytase (myo-inositol hexakisphosphate phosphohydrolase) is any type of phosphatase enzyme that catalyzes the hydrolysis of phytic acid (myo-inositol hexakisphosphate) - an indigestible, organic form of phosphorus that is found in grains and oil seeds - and releases a usable form of inorganic phosphorus. Scope of the Report: This report focuses on the Phytases in global market, especially in North America, Europe and Asia-Pacific, ......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Phytases Market 2018, Forecast to 2023
    Published: 13-Jul-2018        Price: US 4880 Onwards        Pages: 137
    This report studies the Phytases market, A phytase (myo-inositol hexakisphosphate phosphohydrolase) is any type of phosphatase enzyme that catalyzes the hydrolysis of phytic acid (myo-inositol hexakisphosphate) - an indigestible, organic form of phosphorus that is found in grains and oil seeds - and releases a usable form of inorganic phosphorus. Scope of the Report: This report focuses on the Phytases in global market, especially in North America, Europe and Asia-Pacific, ......
  • Global Horseradish Peroxidase (HRP) Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 13-Jul-2018        Price: US 3480 Onwards        Pages: 129
    Pierce Horseradish Peroxidase (HRP) is purified horseradish peroxidase enzyme for use in activity assays and conjugation to antibodies for ELISA, Western blot and Research applications. Scope of the Report: This report focuses on the Horseradish Peroxidase (HRP) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. In the ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs